Immunotherapy Improves Survival in Advanced Esophageal Cancer
Jun 17, 2021 · The approval covers the use of nivolumab plus chemotherapy and nivolumab plus ipilimumab (Yervoy) for the treatment of esophageal squamous cell carcinoma, which starts in the …
Immunotherapy for Esophageal Cancer | Moffitt
The most common types are squamous cell carcinoma, which originates in the cells that line the esophagus, and adenocarcinoma, which originates in the cells that produce and release mucus. …
Immunotherapy for Squamous Esophageal Cancer: A Review
Abstract Esophageal squamous cell carcinoma (ESCC) is a rare gastrointestinal tumour with high mortality. A multimodality treatment based on chemoradiotherapy followed by surgery is the standard …
Neoadjuvant Chemoradiotherapy Plus Immunotherapy in Esophageal Squamous ...
Mar 25, 2025 · The disease has an especially high burden in China, where more than half of global cases occur. In East Asia, both neoadjuvant chemoradiotherapy and chemotherapy are considered …
Expanding Options in Esophageal Cancer - Cancer Today
Jun 12, 2025 · In the study published Nov. 15, 2024, in Clinical Cancer Research, researchers followed 30 people who had esophageal squamous cell carcinoma that had spread to other nearby organs …
Experts Discuss Tislelizumab’s FDA Approval in Esophageal Cancer
Mar 13, 2025 · The FDA approved the combination of tislelizumab-jsg r (Tevimbra) and platinum-containing chemotherapy as a frontline treatment for adult patients with unresectable or metastatic …
Thoracic: Esophageal Cancer - ScienceDirect
Aug 1, 2024 · The study aimed to compare survival after neoadjuvant chemotherapy combined with immunotherapy (NACI) versus after conventional neoadjuvant chemoradiotherapy (NCRT), both …
Real-world study of first-line immunotherapy combined with ...
Aug 4, 2025 · This study aimed to assess the effectiveness, safety, and recurrence patterns of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma (ESCC) …
Patients with Upper Third of Esophageal Squamous Cell Carcinoma …
Mar 26, 2025 · With the successful use of immune checkpoint inhibitors (ICIs) to treat localized or metastatic esophageal cancer (EC), which has revolutionized the treatment of EC, the potential …
Revolutionizing Esophageal Squamous Cell Carcinoma Treatment ...
Jul 10, 2024 · The advent of immunotherapy has significantly transformed the treatment paradigm for esophageal carcinoma. The adjuvant therapy study CheckMate-577 showcased the PD-1 inhibitor …